HIV Gilead - Search Videos

Gilead Sciences Profit Rises on Growth of Liver Disease, HIV Products

Gilead Sciences Profit Rises on Growth of Liver Disease, HIV Products

ADVERTISEMENT by Gilead — Taking Steps Towards a Future Free from HIV

ADVERTISEMENT by Gilead — Taking Steps Towards a Future Free from HIV

Gilead stock falls on report of HIV prevention cuts

Gilead stock falls on report of HIV prevention cuts

6.3K viewsMar 19, 2025

YahooYahoo Finance Video

Gilead TV Spot, 'HIV: March'

Gilead TV Spot, 'HIV: March'

In a First, Drugmaker Gilead Promotes PrEP and HIV Prevention in TV Ads

In a First, Drugmaker Gilead Promotes PrEP and HIV Prevention in TV Ads

This #NHTD, we’re working with our community partners to help reduce stigma in #HIV testing and ensure it’s more accessible. We’re helping increase HIV testing, advance innovation and address systemic barriers to care to help end the HIV epidemic. | Gilead Sciences

This #NHTD, we’re working with our community partners to help reduce stigma in #HIV testing and ensure it’s more accessible. We’re helping increase HIV testing, advance innovation and address systemic barriers to care to help end the HIV epidemic. | Gilead Sciences

267.3K viewsJun 27, 2024

FacebookGilead Sciences

This #HLTSAD, we honor the resilience and strength of #HIV long-term survivors. We’re dedicated to helping improve the quality of life and health for people aging with HIV. | Gilead Sciences

This #HLTSAD, we honor the resilience and strength of #HIV long-term survivors. We’re dedicated to helping improve the quality of life and health for people aging with HIV. | Gilead Sciences

258.5K viewsJun 5, 2024

FacebookGilead Sciences

Finding an #HIV cure is one of the greatest scientific challenges of our time. Through determination and persistence, we will continue to innovate to find potential new pathways that could one day lead to a cure. #Innovation | #HIVAwareness | Gilead Sciences

105.2K viewsMay 7, 2024

FacebookGilead Sciences

At Gilead, we're focused on delivering transformative therapies in #HIV and pushing the boundaries of scientific innovation in our mission to help end the epidemic. Here's what it takes. | Gilead Sciences

89.9K views10 months ago

FacebookGilead Sciences

At Gilead, we’ve spent decades focusing on #HIV and pushing the boundaries of scientific innovation. The story of HIV prevention is one of persistence, progress and possibility – and we won’t stop until we reach our ultimate goal of ending the epidemic. | Gilead Sciences

77.8K viewsMay 13, 2025

FacebookGilead Sciences

Together with the community, Gilead has been taking on health challenges like HIV for more than 35 years. In recognition of National Gay Men's HIV/AIDS Awareness Day, Alex Kalomparis, SVP of Public Affairs, shares his personal passion for our commitment to supporting the LGBTQ community all year-round through innovative research and collaborations while fostering an internal culture that celebrates and thrives on diversity. #NGMHAAD | #HIV | #Stigma | Gilead Sciences

665 viewsSep 27, 2023

FacebookGilead Sciences

#gileadnews #hiv | Gilead Sciences | 29 comments

29 viewsFeb 18, 2025

Gilead HIV combo of bictegravir & lenacapavir hits phase 3 goal

marketscreener.com

Prevention is essential to helping end the #HIV epidemic, and PrEP (pre-exposure prophylaxis) is a key piece of the puzzle. At Gilead, we’re working to turn possibility into progress as we strive to reach more people with new PrEP options. | Gilead Sciences

44.1K views10 months ago

FacebookGilead Sciences

Gilead Sciences: Global Health and Access

Gilead CEO Daniel O’Day breaks down the company's new twice-a-year HIV drug. Watch the full video here: https://cnb.cx/3WeR4Hm | CNBC

1.2K viewsJan 12, 2023

US FDA approves Gilead’s twice-yearly injection for HIV prevention

Hear from Jared Baeten, MD, PhD, Vice President, HIV Clinical Development, as he explains why addressing #HIV treatment resistance, which cannot be reversed once it occurs, is critical to our efforts to help end the epidemic. | Gilead Sciences

721.7K viewsFeb 29, 2024

FacebookGilead Sciences

On HIV Long-Term Survivors Awareness Day, we honor the strength and stories of those who have lived with #HIV for decades — including Kim Canady. Born with HIV, she’s an advocate and role model for others living with HIV, by choosing to be a mom and wife instead of being defined by being born with HIV. At Gilead, our work is rooted in partnership with the communities most affected by the epidemic to promote prevention and treatment strategies while advocating for policies that help ensure everyo

6.2K views11 months ago

FacebookGilead Sciences

PrEP is a proven tool to prevent HIV, but its impact depends on access. Today, PrEP isn’t reaching many people who need it. Barriers like stigma, lack of access to PrEP providers and low awareness continue to stand in the way. To change the future of HIV and help end the epidemic, we need to expand access not just where it’s easy, but where it’s essential. | Gilead Sciences

153 views6 months ago

FacebookGilead Sciences

Our novel #HIV prevention medicine was named one of @TIME's Best Inventions of 2025. At Gilead, creating possible is never a finish line. It’s a journey driven by dedicated teams, powerful communities and bold science. This award honors decades of progress and fuels our commitment to what’s next as we work to help end the HIV epidemic. | Gilead Sciences

22.6K views7 months ago

FacebookGilead Sciences

We’ve been working to advance #HIV innovation for decades, and we’re committed to creating options that help address the diverse needs and preferences of people who need or want PrEP. Hear the perspectives from three HIV advocates on the value of HIV prevention and what it means for individuals and society. | Gilead Sciences

89.8K views10 months ago

FacebookGilead Sciences

FDA Approves Gilead’s Twice-Yearly Injectable Lenacapavir (Yeztugo) for HIV Prevention | Contagion Live

contagionlive.com

FDA approves Gilead's next-generation HIV PrEP pill, Descovy

NBC NewsTim Fitzsimons

Women are at the forefront as leaders, innovators and changemakers in ending #HIV. Whether it’s driving cutting-edge research, spreading awareness or advocating for the health of their own and others, each contribution helps advance public health. Hear more from #IAS2025 on the importance of women leading innovation in HIV. | Gilead Sciences

99.5K views9 months ago

FacebookGilead Sciences

AIDS Healthcare Foundation calls out Gilead Sciences over the high cost of HIV medications in Florida

MSNABC 27 Tallahassee,FL

For nearly a decade, the Gilead Research Scholars Program has funded early-career investigators who work to advance scientific knowledge in areas of unmet medical need for people affected by #HIV. Here’s a look at three of the scientists: https://gilead.inc/45I2TKU | Gilead Sciences

288 viewsOct 17, 2023

FacebookGilead Sciences

Gilead Sciences CEO on FDA approval of Yeztugo: A milestone moment in the history of HIV

At Gilead, we work in close partnership with organizations that share our ambitions. For the past 15 years we’ve collaborated with Emory University on AIDSVu, an online mapping tool that helps communities better understand what #HIV looks like across the United States. Watch to learn how this tool can help us get closer to our goal of ending the epidemic. https://gilead.inc/3GgOTjS | Gilead Sciences

276 viewsApr 9, 2025

FacebookGilead Sciences

Gilead Signs Deal to Expand HIV Drug Access in 120 Developing Healthawareness

See more